[Form 4] Genasys Inc. Insider Trading Activity
Richard Hoe Osgood III, a director of Genasys Inc. (GNSS), reported a non‑derivative acquisition of 6,411 shares of the company's common stock on 10/01/2025. The shares were granted in lieu of an accrued cash retainer for the third and fourth quarters of fiscal 2025, with the share count determined by dividing the cash value of the retainer by the closing stock price on the grant date. After the grant, the reporting person beneficially owns 552,430 shares. The Form 4 was signed by an attorney‑in‑fact on 10/03/2025.
This filing documents routine director compensation paid in equity rather than cash, increasing the director's direct holdings and reflecting standard corporate governance practice to align board members with shareholder interests.
- 6,411 shares granted aligns director compensation with shareholder interests by using equity
- Grant in lieu of cash preserves company cash while compensating the director
- Issuing 6,411 shares increases share count and causes dilution for existing shareholders (amount not quantified in filing)
Insights
Director accepted equity compensation of 6,411 shares instead of cash.
This Form 4 shows a board member of Genasys (GNSS) received 6,411 shares on 10/01/2025 in lieu of a cash retainer for Q3 and Q4 FY2025. The payment method ties board pay to shareholder value because the share count was set by the closing price on the grant date.
The grant increased the director's direct beneficial ownership to 552,430 shares, a disclosure relevant to insider holdings and governance transparency. Because this is compensation rather than a market trade, it is routine and does not directly indicate a personal view on the stock price.
Equity in lieu of cash preserves company cash and issues a fixed share amount tied to market price.
Issuing 6,411 shares instead of cash reduces immediate cash outflow for the company and grants equity-based alignment for the director. The number of shares was calculated by dividing the accrued cash retainer by the closing stock price on the grant date, as disclosed.
This is a standard practice for boards; the filing documents the mechanics and resulting ownership of 552,430 shares, which investors can use to track insider concentration.